1392072-52-4 Usage
Description
(rac)-6-bromo-2,3-dihydrobenzofuran-3-ol is a racemic mixture of two enantiomers, existing as a white to off-white solid with a molecular formula of C8H9BrO2. This chemical compound features a benzofuran structure, which is a heterocyclic compound consisting of a benzene ring fused to a five-membered oxygen-containing ring.
Uses
Used in Pharmaceutical Synthesis:
(rac)-6-bromo-2,3-dihydrobenzofuran-3-ol is utilized as a building block in organic synthesis, particularly for the preparation of various pharmaceuticals and biologically active molecules. Its unique structure contributes to the development of new drugs with potential therapeutic applications.
Used in Medicinal Chemistry:
(rac)-6-bromo-2,3-dihydrobenzofuran-3-ol has been studied for its potential medicinal properties, including anti-inflammatory and anti-cancer activities. Its ability to modulate biological processes makes it a promising candidate for further research and development in the field of medicine.
Used in Chemical Research:
As a compound with a distinct structure, (rac)-6-bromo-2,3-dihydrobenzofuran-3-ol serves as a valuable subject for chemical research. It can be used to explore new reaction pathways, understand the relationship between structure and biological activity, and develop innovative synthetic methods for complex molecular structures.
Check Digit Verification of cas no
The CAS Registry Mumber 1392072-52-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,9,2,0,7 and 2 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1392072-52:
(9*1)+(8*3)+(7*9)+(6*2)+(5*0)+(4*7)+(3*2)+(2*5)+(1*2)=154
154 % 10 = 4
So 1392072-52-4 is a valid CAS Registry Number.
1392072-52-4Relevant articles and documents
DIHYDROBENZOFURAN AND INDEN ANALOGS AS CARDIAC SARCOMERE INHIBITORS
-
Paragraph 0389, (2019/08/08)
Provided are compounds of Formula (I), or a pharmaceutically acceptable salt thereof, wherein A, Z, B, R1, R2, R3, G1, G2, and G3 are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula (I), or a pharmaceutically acceptable salt thereof Also provided are methods of using a compound of Formula (I), or a pharmaceutically acceptable salt, thereof for use in methods of treatment heart diseases through cardiac sarcomere inhibtion.
NEW ARYL-BENZOCYCLOALKYL AMIDE DERIVATIVES
-
Page/Page column 56, (2012/08/08)
The invention provides novel compounds having the general Formula (I), wherein R1, R2, R3, R4 R5, R6, R7, R8 R9, R10, R11, R12, A1, A2 and n are as described herein, compositions including the compounds and methods of using the compounds.
